AQR Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-409,037
| Closed | -$1.68M | – | 2347 |
|
|
2022
Q1 | $1.68M | Sell |
409,037
-11,803
| -3% | -$42.8K | ﹤0.01% | 1288 |
|
|
2021
Q4 | $1.5M | Buy |
420,840
+170,585
| +68% | +$597K | ﹤0.01% | 1348 |
|
|
2021
Q3 | $911K | Sell |
250,255
-37,112
| -13% | -$150K | ﹤0.01% | 1591 |
|
|
2021
Q2 | $1.25M | Sell |
287,367
-213,353
| -43% | -$869K | ﹤0.01% | 1477 |
|
|
2021
Q1 | $2.06M | Sell |
500,720
-188,872
| -27% | -$818K | ﹤0.01% | 1188 |
|
|
2020
Q4 | $2.75M | Sell |
689,592
-38,976
| -5% | -$126K | ﹤0.01% | 1006 |
|
|
2020
Q3 | $1.97M | Sell |
728,568
-122,735
| -14% | -$340K | ﹤0.01% | 1115 |
|
|
2020
Q2 | $2.34M | Buy |
851,303
+754,597
| +780% | +$2.11M | ﹤0.01% | 1090 |
|
|
2020
Q1 | $228K | Buy |
96,706
+48,995
| +103% | +$167K | ﹤0.01% | 1850 |
|
|
2019
Q4 | $224K | Sell |
47,711
-19,792
| -29% | -$81K | ﹤0.01% | 1982 |
|
|
2019
Q3 | $226K | Sell |
67,503
-1,790
| -3% | -$5.89K | ﹤0.01% | 1981 |
|
|
2019
Q2 | $228K | Hold |
69,293
| – | – | ﹤0.01% | 1945 |
|
|
2019
Q1 | $210K | Buy |
69,293
+16,259
| +31% | +$52.7K | ﹤0.01% | 2065 |
|
|
2018
Q4 | $144K | Sell |
53,034
-3,478
| -6% | -$11.5K | ﹤0.01% | 2118 |
|
|
2018
Q3 | $190K | Sell |
56,512
-21,529
| -28% | -$66.5K | ﹤0.01% | 2200 |
|
|
2018
Q2 | $201K | Sell |
78,041
-35,065
| -31% | -$87.3K | ﹤0.01% | 2222 |
|
|
2018
Q1 | $249K | Sell |
113,106
-58,733
| -34% | -$132K | ﹤0.01% | 2083 |
|
|
2017
Q4 | $342K | Buy |
171,839
+24,745
| +17% | +$53.9K | ﹤0.01% | 2028 |
|
|
2017
Q3 | $477K | Buy |
+147,094
| New | +$454K | ﹤0.01% | 1954 |
|
|
2014
Q3 | – | Sell |
-27,731
| Closed | -$74K | – | 2618 |
|
|
2014
Q2 | $74K | Sell |
27,731
-65,900
| -70% | -$198K | ﹤0.01% | 2483 |
|
|
2014
Q1 | $328K | Hold |
93,631
| – | – | ﹤0.01% | 2226 |
|
|
2013
Q4 | $419K | Hold |
93,631
| – | – | ﹤0.01% | 2150 |
|
|
2013
Q3 | $380K | Hold |
93,631
| – | – | ﹤0.01% | 2109 |
|
|
2013
Q2 | $390K | Buy |
+93,631
| New | +$362K | ﹤0.01% | 1984 |
|
Other funds holding ATRS
AQR Capital Management's ATRS Position: Q2 2022 in Review
AQR Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 409,037 shares — an estimated $1.68M sold.
AQR Capital Management first reported a position in ATRS in Q2 2013 and held it in 24 quarters. The position peaked at $2.75M in Q4 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- AQR Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- AQR Capital Management sold 409,037 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.68M.
- AQR Capital Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 24 quarters.
- AQR Capital Management's Antares Pharma, Inc. position peaked at $2.75M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.